https://www.thebodypro.com/author/nelson-vergel
Nelson Vergel, B.S.Ch.E., M.B.A. Img

Nelson Vergel, B.S.Ch.E., M.B.A.

Nelson Vergel is a chemical engineer who has become a leading advocate for sports nutrition, supplementation and the promotion of wellness in the HIV-positive community since his positive diagnosis in 1986. He is also the author of "Testosterone: A Man's Guide" and co-author of the book "Built to Survive"; the founder of the nonprofit organizations Body Positive Wellness Clinic and Program for Wellness Restoration; the Nutrition and Exercise forum expert at TheBody.com; and a bilingual speaker on lipodystrophy, wasting, exercise, nutrition, testosterone replacement, metabolic disorders, HIV medication side effect management and HIV salvage therapy. Nelson also moderates PozHealth, one of the largest HIV health discussion listservs online.

Latest by Nelson Vergel, B.S.Ch.E., M.B.A.

Promo Image
Older Adults (Ages 50+)

Nelson Vergel Asks for Change in Testosterone Guidelines After Another Negative Study

A new study published last week and a previous one from the Veterans Administration Hospital System (see below post) show what happens when older men are given testosterone replacement without managing potential blood level increases of factors that ...

What's New and Notable in HIV Cure Research? Img

What's New and Notable in HIV Cure Research?

Nelson Vergel sits down with leading HIV cure research activist Richard Jefferys for an update on the important aspects of, and controversies in, our current efforts toward eliminating the virus.

What Can We Look Forward to in HIV Cure Research? Img

What Can We Look Forward to in HIV Cure Research?

The drive to develop a cure for HIV is moving forward on several fronts, explains research advocate Richard Jeffreys.

Innovative HIV Gene Therapy Study Soon to Start Enrollment: A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. Img

Innovative HIV Gene Therapy Study Soon to Start Enrollment: A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A.

"Calimmune, a small biotechnology company, has been given the go-ahead ... to start enrolling HIV-infected people in a first-of-its-kind gene therapy study that will modify two HIV attachment sites in CD4+ cells," HIV treatment advocate Nelson Vergel...

How Can "JAK Inhibitors" Help Salvage Patients and the Search for an HIV Cure? A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. Img

How Can "JAK Inhibitors" Help Salvage Patients and the Search for an HIV Cure? A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A.

"As part of my work as an HIV cure and salvage treatment activist, I am constantly searching for treatment options that could ... help patients with multidrug resistance and at the same time be used as an approach to cure HIV," Nelson Vergel writes. ...

"Immune" to HIV? Not So Fast Img
Conference Coverage

"Immune" to HIV? Not So Fast

A particular type of mutation renders people with HIV effectively immune to most strains of the virus. (The "Berlin patient," Timothy Brown, was essentially "given" this type of mutation.) But as a new case report shows, these individuals are still v...

HIV Linked to Shorter Telomeres, a Sign of Aging Img
Older Adults (Ages 50+)

HIV Linked to Shorter Telomeres, a Sign of Aging

A telomere is a repeating sequence of nucleotides that protects the end of a chromosome. Telomeres shorten with aging. HIV-induced inflammation and the use of nucleoside analog drugs may accelerate telomere shortening.

A team from the University of ...

Impact of Monocytes on Inflammation and Aging in HIV Img
Older Adults (Ages 50+)

Impact of Monocytes on Inflammation and Aging in HIV

This study compared a small group of HIV-infected women with matched HIV-uninfected controls and found that HIV-infected women had similar levels of immune activation of monocytes compared to HIV-uninfected women 16 years older.

Monocytes are critic...

Some HIV-Infected People Develop Spontaneous Control of HIV After Short-Term HAART During Acute Infection Img
Conference Coverage

Some HIV-Infected People Develop Spontaneous Control of HIV After Short-Term HAART During Acute Infection

If a person takes HIV meds for a year or two beginning immediately after they're infected, can their immune system gain the ability to hold off HIV on its own, without treatment, for years? New research suggests it's possible.

Promo Image

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

The dolutegravir expanded access program (EAP) has been designed to provide free access to Shionogi-ViiV Healthcare's investigational integrase inhibitor, dolutegravir (DTG, S/GSK1349572) in an open-label protocol program to adults living with HIV wh...